FDA Issues Recall for Hydroxycut Products
Contributor
(866) 735-1102 Ext 346
The U.S. Food and Drug Administration have issued a warning to consumers to immediately stop using Hydroxycut products over concerns of serious liver injuries associated with some Hydroxycut products. Iovate Health Sciences, the manufacturer of Hydroxycut, agreed recall their products from the market.
The FDA has received at least 23 reports of serious health problems associated with the use of Hydroxycut. Liver problems related to the use of Hydroxycut have ranged from jaundice and elevated liver enzymes to severe liver damage requiring a transplant. One death resulting from liver failure associated with the use of Hydroxycut has been reported to the FDA. Other Hydroxycut users have reported additional health problems including seizures, cardiovascular disorders, and rhabdomyolysis.
Liver injury, although rare, was reported by patients at the doses of Hydroxycut recommended on the bottle. Symptoms of liver injury include jaundice (yellowing of the skin or whites of the eyes) and brown urine. Other symptoms include nausea, vomiting, light-colored stools, excessive fatigue, weakness, stomach or abdominal pain, itching, and loss of appetite.
Hydroxycut products were among the most popular dietary supplements available, controlling over 90 percent of the market in some areas.
Although the FDA has not received complaints of adverse reactions associated with all Hydroxycut products, Iovate has agreed to recall all of the products listed below.
Hydroxycut Regular Rapid Release Caplets
Hydroxycut Caffeine-Free Rapid Release Caplets
Hydroxycut Hardcore Liquid Caplets
Hydroxycut Max Liquid Caplets
Hydroxycut Regular Drink Packets
Hydroxycut Caffeine-Free Drink Packets
Hydroxycut Hardcore Drink Packets (Ignition Stix)
Hydroxycut Max Drink Packets
Hydroxycut Liquid Shots
Hydroxycut Hardcore RTDs (Ready-to-Drink)
Hydroxycut Max Aqua Shed
Hydroxycut 24
Hydroxycut Carb Control
Hydroxycut Natural
For more information:
Hydroxycut Products
Dietary Supplements -- Overview
FDA 101: Dietary Supplements
NIH Office of Dietary Supplements